Literature DB >> 418443

Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole.

B N Rosloff, J M Daivis.   

Abstract

Previous studies have suggested that chronic treatment with tricyclic antidepressants alters brain NE turnover. This action is more likely a biochemical correlate of their clinical effect than is the blockade of amine reuptake, because the latter occurs with acute administration, whereas tricyclics must be given chronically for clinical improvement. In this paper the effects of chronic treatment with the tricyclics desmethylimipramine (DMI) and iprindole (a clinically effective tricyclic that does not potently block amine reuptake) on rat brain NE turnover, as measured by the Conversion Index, was studied. Chronic DMI, but not iprindole, decreased NE turnover. These results are discussed regarding the proposed mechanism of action of tricyclics and the 'catecholamine hypothesis of affective disorders'. Chronic DMI also tended to decrease endogenous brain NE, and chronic treatment with either DMI or iprindole tended to decrease brain and plasma tyrosine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418443     DOI: 10.1007/bf00432858

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

Authors:  J GLOWINSKI; J AXELROD
Journal:  Nature       Date:  1964-12-26       Impact factor: 49.962

2.  Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain.

Authors:  J Schubert; H Nybäck; G Sedvall
Journal:  J Pharm Pharmacol       Date:  1970-02       Impact factor: 3.765

3.  The effect of imipramine on central 5-hydroxytryptamine neurons.

Authors:  A Carlsson; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1968-02       Impact factor: 3.765

4.  Iprindole in neurotic depressed general practice patients: a controlled study.

Authors:  K Rickels; P E Gordon; R Meckelnburg; L Sablosky; E M Whalen; H Dion
Journal:  Psychosomatics       Date:  1968 Jul-Aug       Impact factor: 2.386

5.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

6.  A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices.

Authors:  S B Ross; A L Renyi; S O Ogren
Journal:  Life Sci I       Date:  1971-11-15

Review 7.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

8.  Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine.

Authors:  J J Schildkraut; E K Gordon; J Durell
Journal:  J Psychiatr Res       Date:  1965-12       Impact factor: 4.791

9.  Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.

Authors:  A Carlsson; K Fuxe; B Hamberger; M Lindqvist
Journal:  Acta Physiol Scand       Date:  1966 Jul-Aug

10.  Brain catechol synthesis: control by train tyrosine concentration.

Authors:  R J Wurtman; F Larin; S Mostafapour; J D Fernstrom
Journal:  Science       Date:  1974-07-12       Impact factor: 47.728

View more
  6 in total

1.  Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.

Authors:  D S Charney; A Breier; P I Jatlow; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine.

Authors:  P Willner; T Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Antidepressant drugs and ethanol: behavioral and pharmacokinetic interactions in mice.

Authors:  J M Cott; S O Ogren
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Interaction of triazolam with desipramine. Effects of single and repeated treatment on certain pharmacologic responses and brain catecholamine levels.

Authors:  M Kusaka; A Horikawa; T Meshi; Y Maruyama
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.